Evidence map›Paper›PMID 30361772›Full record

ArticleEnvironmental monitoring and assessment2018

Meropenem-resistant bacteria in hospital effluents in Seoul, Korea.

Sung Ho Hwang, Young Jin Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental monitoring and assessment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Complete genome sequence of carbapenem-resistant pathogenicMicrobiology resource announcements · 2024
    Article
  2. Clinically Relevant β-Lactam Resistance Genes in Wastewater Treatment Plants.International journal of environmental research and public health · 2022
    Review
  3. Active antibiotic resistome in soils unraveled by single-cell isotope probing and targeted metagenomics.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sung Ho HwangNational Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, South Korea.
Young Jin KimChungRyong Environment Co., Ltd., 5-209,20, Digital-ro 31-gil, Guro-gu, Seoul, South Korea. jin2701@hanmail.net.
National Cancer Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to understand the prevalence, diversity, antibiotic resistance, β-lactamase gene types, and possibility of environmental survival of meropenem-resistant bacteria present in hospital effluents in Seoul, Korea. Water sampling was performed at five general hospitals in Seoul, Korea, in January 2017. Water samples were plated in triplicate on tryptic soy agar plates with 16 mg/L meropenem. Meropenem-resistant bacteria were selected and subjected to 16S rRNA analysis for species determination and PCR for identification of β-lactamase gene types. Resistant bacteria were cultured in sterilized surface water. Meropenem-resistant bacteria exhibited resistance to more than 12 antibiotics and possessed several β-lactamase genes, such as those encoding OXT-M, NDM-1, AmpC, and OXA. They were able to multiply and survive in sterilized surface water for up to 60 days. Multidrug-resistant bacteria represent an environmental health risk, as they can survive in the environment for an extended period of time. Therefore, these bacteria should be monitored before discharge.

Indexed as

Anti-Bacterial AgentsBacteriabeta-LactamasesDrug Resistance, Multiple, BacterialEnvironmental MonitoringHospitalsHumansMeropenemMicrobial Sensitivity TestsRNA, Ribosomal, 16SSeoulAnti-Bacterial Agentsbeta-LactamasesMeropenemRNA, Ribosomal, 16SCarbapenemDisinfectionHospital effluentMeropenemMultidrug resistanceβ-Lactamase gene

Identifiers

PMID30361772
OpenAlexW2898275823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.